The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini FDA Warning Letter to Neil R. Feins, M.D. 2009 05 20 Circare Heard about BPC 157 in health and wellness products? Think it's a "miracle" peptide? Think again. Claims about BPC 157 are based on lab or animal studies, NOT human clinical studies. What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B FDA Moves to Reevaluate Several Peptides American Med Spa Association